300584 海辰药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.4594.0013.7483.41435.075
总资产报酬率 ROA (%)1.0222.7992.6872.50025.889
投入资产回报率 ROIC (%)1.1063.0272.9042.67427.395

边际利润分析
销售毛利率 (%)86.09083.15181.34675.30481.150
营业利润率 (%)11.5798.2897.5885.71857.287
息税前利润/营业总收入 (%)12.6919.9388.6996.66558.321
净利润/营业总收入 (%)10.4897.9637.0136.10249.252

收益指标分析
经营活动净收益/利润总额(%)113.079121.168112.609125.6437.510
价值变动净收益/利润总额(%)-0.0460.0080.1063.22992.697
营业外收支净额/利润总额(%)-1.013-1.896-4.254-4.605-0.258

偿债能力分析
流动比率 (X)1.0121.0650.9431.1931.002
速动比率 (X)0.7540.8100.7390.9910.819
资产负债率 (%)28.80629.11329.90826.53727.153
带息债务/全部投入资本 (%)22.76322.98322.70818.33718.550
股东权益/带息债务 (%)333.813329.079333.256433.349416.264
股东权益/负债合计 (%)243.593239.916234.355276.827268.811
利息保障倍数 (X)10.3315.5136.1225.55849.384

营运能力分析
应收账款周转天数 (天)106.112138.243136.316101.31661.430
存货周转天数 (天)390.698353.993271.296165.152209.273